Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 2:42 pm Purchase | 2023-12-31 | 13G | Biodexa Pharmaceuticals Plc BDRX | Armistice Capital, LLC | 100 0.940% | 100 (New Position) | Filing History |
| 2024-02-14 2:41 pm Purchase | 2023-12-31 | 13G | Avinger, Inc. AVGR | Armistice Capital, LLC | 67,226 4.990% | 67,226 (New Position) | Filing History |
| 2024-02-14 2:41 pm Sale | 2023-12-31 | 13G | Autolus Therapeutics plc AUTL | Armistice Capital, LLC | 3,850,000 2.210% | -6,374,000 (-62.34%) | Filing History |
| 2024-02-14 2:40 pm Sale | 2023-12-31 | 13G | Applied Therapeutics, Inc. APLT | Armistice Capital, LLC | 0 0.000% | -5,333,951 (Position Closed) | Filing History |
| 2024-02-14 2:39 pm Sale | 2023-12-31 | 13G | Acurx Pharmaceuticals, Inc. ACXP | Armistice Capital, LLC | 36,155 4.990% | -7,845 (-17.83%) | Filing History |
| 2024-02-14 2:38 pm Purchase | 2023-12-31 | 13G | Abeona Therapeutics Inc. ABEO | Armistice Capital, LLC | 1,301,114 4.990% | 195,114 (+17.64%) | Filing History |
| 2024-02-14 2:35 pm Purchase | 2023-12-31 | 13G | Voyager Therapeutics, Inc. VYGR | Armistice Capital, LLC | 4,236,000 9.630% | 840,000 (+24.73%) | Filing History |
| 2024-02-14 2:35 pm Purchase | 2023-12-31 | 13G | Travere Therapeutics, Inc. TVTX | Armistice Capital, LLC | 7,384,000 9.830% | 972,000 (+15.16%) | Filing History |
| 2024-02-14 2:34 pm Purchase | 2023-12-31 | 13G | Trevena, Inc. TRVN | Armistice Capital, LLC | 73,105 9.990% | 41,711 (+132.87%) | Filing History |
| 2024-02-14 2:34 pm Purchase | 2023-12-31 | 13G | TC Biopharm (Holdings) Plc TCBP | Armistice Capital, LLC | 828 9.990% | 828 (New Position) | Filing History |
| 2024-02-14 2:33 pm Purchase | 2023-12-31 | 13G | Supernus Pharmaceuticals, Inc. SUPN | Armistice Capital, LLC | 4,650,000 8.510% | 294,000 (+6.75%) | Filing History |
| 2024-02-14 2:32 pm Purchase | 2023-12-31 | 13G | Presidio Property Trust, Inc. SQFT | Armistice Capital, LLC | 145,726 9.990% | 9,953 (+7.33%) | Filing History |
| 2024-02-14 2:32 pm Purchase | 2023-12-31 | 13G | Sadot Group Inc. SDOT | Armistice Capital, LLC | 41,152 8.110% | 9,133 (+28.52%) | Filing History |
| 2024-02-14 2:31 pm Purchase | 2023-12-31 | 13G | Stronghold Digital Mining, Inc. SDIG | Armistice Capital, LLC | 1,028,642 9.990% | 797,127 (+344.31%) | Filing History |
| 2024-02-14 2:31 pm Purchase | 2023-12-31 | 13G | Rockwell Medical, Inc. RMTI | Armistice Capital, LLC | 3,380,534 9.990% | 2,164,820 (+178.07%) | Filing History |
| 2024-02-14 2:30 pm Purchase | 2023-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL | Armistice Capital, LLC | 1,710,000 9.810% | 14,400 (+0.85%) | Filing History |
| 2024-02-14 2:29 pm Purchase | 2023-12-31 | 13G | Protagenic Therapeutics, Inc. PTIX | Armistice Capital, LLC | 17,143 5.130% | 17,143 (New Position) | Filing History |
| 2024-02-14 2:29 pm Sale | 2023-12-31 | 13G | MacroGenics, Inc. MGNX | Armistice Capital, LLC | 4,572,000 7.370% | -1,520,000 (-24.95%) | Filing History |
| 2024-02-14 2:28 pm Purchase | 2023-12-31 | 13G | InMed Pharmaceuticals Inc. INM | Armistice Capital, LLC | 1,516 9.990% | 1,101 (+265.88%) | Filing History |
| 2024-02-14 2:27 pm Unchanged | 2023-12-31 | 13G | Globus Maritime Limited GLBS | Armistice Capital, LLC | 1,200,000 5.510% | 0 (Unchanged) | Filing History |